Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour Transcript

SA Transcripts 162.02K Followers Follow Daré Bioscience, Inc. ( DARE ) Discusses Women's Health Portfolio and Commercial Launches During Virtual Bus Tour August 26, 2026 3:30 PM EDT Company Participants Sabrina Johnson - CEO, President, Principal Financial Officer, Secretary & Director Conference Call Participants Jenene Thomas - Jenene Thomas Communications, LLC Presentation Jenene Thomas Jenene Thomas Communications, LLC Okay. We are ready to get started. Welcome, and thank you for joining the Dare Bioscience's Virtual Bus Tour. My name is Jenene Thomas. I am CEO of JTC IR, and I will be the moderator for today's event. So today, the company completes its virtual bus tour series with the East Coast stop. And for the format today, Sabrina Martucci Johnson, President and Chief Executive Officer of Dare Bioscience, will take you through the Dare story, and then I will open it up for Q&A and take your questions. So it is now my pleasure to turn it over to Sabrina Martucci Johnson, to take it away. Sabrina? Sabrina Johnson CEO, President, Principal Financial Officer, Secretary & Director Thank you so much, and thank you all of you for tuning in today on the bus tour. Before I start, obviously, the presentation does contain forward-looking statements. So I do encourage you to look at our SEC filings for a full overview of the risks and uncertainties associated with the company. So those of you who know us know we really think of ourselves as a purpose-driven biotech, where our sole focus is to close the gap between promising science and real-world solutions for women. And what does that mean, right? That means that we're focused exclusively on women's health conditions. And as you'll see, as I talk about the portfolio, we work very broadly in the space. And as you're looking at us now and some of the things I want to highlight